Amanta Healthcare Limited (NSE:AMANTA)
108.56
-0.60 (-0.55%)
At close: Feb 12, 2026
Amanta Healthcare Cash Flow Statement
Financials in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 | Mar '21 Mar 31, 2021 |
Net Income | 105.01 | 36.33 | -21.11 | 538.82 | -218.34 |
Depreciation & Amortization | 182.75 | 196.6 | 182.77 | 172.09 | 169.4 |
Other Amortization | 1.24 | 0.7 | 0.7 | 0.7 | 0.84 |
Loss (Gain) From Sale of Assets | 1 | 0.25 | 4.64 | - | 1.53 |
Loss (Gain) From Sale of Investments | -5.01 | -2.48 | -1.33 | -1.31 | - |
Provision & Write-off of Bad Debts | 13.17 | 8.39 | 14.49 | 9.12 | 21.22 |
Other Operating Activities | 278.55 | 291.2 | 318.94 | -171.39 | 485.1 |
Change in Accounts Receivable | -13.08 | 47.25 | -96.46 | 55.2 | -13.64 |
Change in Inventory | -135.29 | 94.74 | 21.78 | -138.58 | -179.06 |
Change in Accounts Payable | 55.12 | -112.75 | -35.74 | 144.36 | 80.99 |
Change in Unearned Revenue | -22.15 | 29.62 | 14.42 | 6.45 | - |
Change in Other Net Operating Assets | 4.9 | -9.11 | 22.71 | 19.89 | -14.11 |
Operating Cash Flow | 466.2 | 580.73 | 425.8 | 635.34 | 333.94 |
Operating Cash Flow Growth | -19.72% | 36.38% | -32.98% | 90.26% | -15.38% |
Capital Expenditures | -207.74 | -134.11 | -62.91 | -99.72 | -134.86 |
Sale of Property, Plant & Equipment | 1.86 | 14.27 | 0.06 | 71.6 | 15.23 |
Investment in Securities | -41.93 | 13.02 | -4.67 | -29.25 | -52.98 |
Other Investing Activities | 3.09 | 3.61 | 2.2 | 3.56 | 5.95 |
Investing Cash Flow | -244.73 | -103.21 | -65.32 | -53.81 | -166.66 |
Short-Term Debt Issued | - | 70.38 | - | 34.19 | 36.73 |
Long-Term Debt Issued | 1,280 | 263.99 | 128.53 | 1,651 | 38 |
Total Debt Issued | 1,280 | 334.36 | 128.53 | 1,685 | 74.73 |
Short-Term Debt Repaid | -21.64 | - | -65.74 | - | - |
Long-Term Debt Repaid | -1,400 | -525.01 | -190.8 | -1,792 | -39.94 |
Total Debt Repaid | -1,421 | -525.01 | -256.53 | -1,792 | -39.94 |
Net Debt Issued (Repaid) | -141.43 | -190.64 | -128 | -106.95 | 34.79 |
Issuance of Common Stock | 200 | - | - | - | - |
Preferred Dividends Paid | -10 | -10.02 | -5.04 | - | - |
Dividends Paid | -10 | -10.02 | -5.04 | - | - |
Other Financing Activities | -283.23 | -262.57 | -290.17 | -412.92 | -210.54 |
Financing Cash Flow | -234.66 | -463.24 | -423.21 | -519.87 | -175.75 |
Net Cash Flow | -13.19 | 14.28 | -62.72 | 61.66 | -8.47 |
Free Cash Flow | 258.46 | 446.62 | 362.9 | 535.62 | 199.08 |
Free Cash Flow Growth | -42.13% | 23.07% | -32.25% | 169.05% | -30.64% |
Free Cash Flow Margin | 9.41% | 15.93% | 14.00% | 23.76% | 11.62% |
Free Cash Flow Per Share | 9.14 | 16.65 | 13.53 | 19.96 | 7.42 |
Cash Interest Paid | 203.62 | 250.17 | 281.32 | 404.37 | 210.54 |
Cash Income Tax Paid | 38 | 59.46 | 63.11 | 0.97 | -51.75 |
Levered Free Cash Flow | -83.4 | 135.23 | -26.02 | 191.65 | -168.36 |
Unlevered Free Cash Flow | 85.13 | 337.72 | 188.88 | 460.76 | 69.72 |
Change in Working Capital | -110.5 | 49.74 | -73.3 | 87.32 | -125.82 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.